Study Group: Physicians who Treat Schizophrenia (US)(?)
Council Members in this Study Group: 326
Request a survey with this Study Group
Leading Experts in this Study Group
Psychiatrist
North Scottsdale Psychiatric Specialists
Robert Schulte, MD, is a Private Practitioner and a Psychiatrist at North Scottsdale Psychiatric Specialists in Arizona. He is board certified in Adult Psychiatry and Child and Adolescent Psychiatry with extensive experience with children and adult's re-psychotherapy and psychopharmacology and the treatment...
Owner
Amit Vijapura, MD
Amit Vijapura, MD, is a Private Practitioner in Psychiatry based in Florida. He has over 15 years of experience in the field and has expertise in depression, bipolar disorder, anxiety disorder, attention deficient disorder, and schizophrenia. Dr. Vijapura is board certified in Psychiatry and is also...
Founder and Director
Institute for Integrative Psychiatry
Rami Kaminski, MD, is Director and Founder of the Institute for Integrative Psychiatry in New York, a not-for-profit organization aimed at evaluating current psychiatric services and how they integrate with medicine, such as the mutual effects between medical and psychiatric conditions. Prior to that,...
President
Red Oak Psychiatry Associates, P. A.
Lawrence Ginsberg, MD, is President and CEO of Red Oak Psychiatry Associates, PA, a multidisciplinary mental health group in Houston, Texas. Dr. Ginsberg's research interests include psychopharmacology, addiction medicine, and forensic psychiatry. His areas of clinical expertise are attention deficit...
Related Study Groups
| Study Group Name | Members |
|---|---|
| Psychiatrists (US) | 1105 |
| Psychiatrists | 1442 |
| Physicians who Treat ADHD (US) | 382 |
| Seroquel Prescribers forSchizophrenia (US) | 107 |
| Effexor XR Prescribers (US) | 137 |
| Physicians who Treat Depression (US) | 365 |
| SSRI Prescribers (US) | 243 |
GLG NewsSMAnalyses by this Study Group's Leading Experts(?)
All is not as it seems when reported in the press, especially the non-scientific press.
-Pharmacogenetic tests have not made it into the treatment or assessment process for most physicians. -Until the cost for these tests become negligible -- or, included in the cost of a particular antidepressant -- psychopharmacogenetic testing will not make it into the mainstream.
We need to look to the cause of why we prescribe antipsychotics to patients with dementia. We have very few tools to use and sometimes these drugs are a necessity.
This article clearly describes the Catch-22 in which most doctors, except for those employed by the large institutions, find themselves. We cannot afford to practice the "best" medicine, and yet, if we could, we might well make fewer errors and make medical care for our patients more seamless. ...
Manipulation of the nicotinic receptor is a novel way to treat ADHD which has significant potential to modify the symptoms of this disorder and to enhance learning and memory. We have had some difficulty with side effects of varenicline which is a nicotinic partial agonist used in smoking cessation...
Most Common Company Types:
- Academic Medical Center/Hospital or Clinic
- Office Based Private Practice or Clinic
- Non-Academic Community Hospital or Clinic
- Government/Military Hospital or Clinic
- Other Freestanding Healthcare Facility
- Academic Institution*
Most Common Job Types:
- Physician - Attending Physician
- Owner
- Physician - Director
- Director
- President
- Medical Director
- Physician - Division Head
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms